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FOREWORD 
The world (parenthetically speaking) has a mistaken notion about 
the nature of science and scientists • . . scientists often seem 
to be matter of fact people, unromantic and even hard-headed. 
·That is because the scientific attitude is realistic, as opposed 
to ritualistic. But there is a vague, continuously satisfying 
glow of emotion about any science, and he who has accepted an.d 
learned its discipline is marked for life. (Markowitz, Archibald, 
and Downie, 1964, p. 2) 
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INTRODUCTION 
The many effects of alcoholism have been.investigated over the years 
and yet there are marty questions· that remain to be answered. As it will 
be described later, chronic alcoholism usually leads. to cirrhosis of the 
liver (or Laennec's cirrhosis), portal hypertension, and other physiologi-
cal disorders. Such disorders as esophageal varices, ascites, and the 
establishment of collateral vessels that divert portal blood directly into 
the system~c circulation are directly correlated with portal hypertension. 
It is these collateral vessels, either porto-caval or porto-pulmonary 
shunts, that are of direct interest in this research. 
The main purpose of this research is to investigate the .effects on 
pulmonary function of a porto-caval shunt which changes portal flow. 
Because of the porto-caval shunt, blood is diverted from the mesen-
teric and splanchnic vasculature into the vena cava. As a result of this 
shunt, the lung capillary system receives the metabolites and other ab-
sorbed compounds that originate in the gastrointestinal outflow. There-
fore, digestive compounds· normally removed or altered by the liver may 
alter pulmonary function. 
In the alcoholic human, the study of these effects is complicated by 
the prese~ce of the liver cirrhosis itself, poor diet, smoking, and the 
continued abuse of alcohol. Although it has been demonstrated that porto-
cayal.and porto-pulmonary shunts can develop naturally during the progress 
of the_disease, various types of porto-caval anastomoses are performed 
clinically to relieve the portal hypertensive state. 
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It has been reported in the literature that humans who have cirrhosis 
of.the liver and a surgical porto-caval anastomosis appear to demonstrate 
some cardio-pulmonary dysfunction. The cardio-pulmonary dysfunction in-
cludes pulmonary hypertension, cardiomegaly, and a hypertrophy of the 
i11terstit.ium of the· lung. 
Therefore, the question arises as to whether the disorders observed in 
lung function arise as a result of the cirrhotic liver, the porto-caval 
shunts, or are due to some other possibility, such as smoking. 
In order to demonstrate an altered portal flow and the exposure of 
the lung to portal blood (i.e., hepatic cirrhosis), porto-caval anasto-
moses were performed on five healthy dogs. The surgical procedure is 
known as the Eck fistula (Markowitz et al., 1964, pp. 542-546). Using 
each dog ~sits-own control, pulmonary and liver function studies were 
conducted at various times after surgery in an attempt to determine the 
effects of porto-caval shunts that are independent of the numerous prob-
lems created by liver cirrhosis, smoking, and the abuse of alcohol. 
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REVIEW OF LITERATURE 
·-' 
During the last twenty years, a great quantity of information has 
been compiled on the effects of alcohol on living organisms. These 
effects are numero.us and occur in many organ systems including heart, 
liver and the central nervous system, as described by Lieber (1976}. More 
recently, data have been obtained which suggest an interaction of alcohol 
with the lung. Since alcoholism is such a complex condition with many 
dy.sfunctions occurring simultaneously, it remains difficult to ascertain 
the exact cause or causes for the impairment of lung function (Burch and 
Depasquale, 1967). This review will attempt to develop a foundation of 
literature to support the function of porto-caval shunts in the normal and 
alcoholic individual. 
Alcoholism and the Lung 
Several studies have looked at pulmonary function in alcoholics. 
Banner (1973) studied thirty patients described to be long-term, heavy 
drinkers. Of the eleven pq.tients selected for pulmonary mechanics tests, 
four had normal pulmonary mechanics., four had signs of airway restriction, 
one had signs of emphysema, and two were not consistent with any known 
pulmonary dysfunction. From these data, he suggested that the ultra-
structure of the lung may be damaged by alcohol. Emirgil et al. (1974) 
reported a decrease in total lung capacity, vital capacity, and residual 
volume in twenty-three chronic alcoholics. They suggested alcohol as a 
causative agent in producing lung disease independent of the effects of 
smoking or previous pulmonary infection. Emirgil and Sobol (1977) con-
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firmed the results of Banner (1973) and stated that little information 
exists with regard to the effects of alcohol or the effects of alcohol 
metabolites on the lungs. Furthermore, Emirgil and Sobol observed im-
paired lung function could be related to hepatic dysfunction, not to the 
alcohol itself. 
Ruff et al. (1971) reported that in 80% of the hepatic cirrhosis 
cases studied, the closing volume (the lung volume at which the dependent 
lung zones begin to trap gas as a result of airway closure) was increased 
and exceeded the functional residual capacity (FRC). This indicates some 
of the airways are closed during normal breathing. Two suggestions for 
premature closure were made: 1) the loss of elastic recoil in the de-
pendent. zones of the lungs, and 2) a decrease in resistance during me-
chani~al compression of the small airways from distended vessels and from 
interstitial pulmonary .edema. 
It was suggested by Ruff et al. (1971) that the compression of small 
airways and presence of interstitial pulmonary edema was responsible for 
the impaired diffusion and lowered arterial oxygen levels in cases of 
liver cirrhosis. Although no direct evidence of pulmonary· edema was found 
by Ruff et al., separate necropsy studies by Berthelot et ·al. (1966) and 
Cameron· (1948) not only demonstrate dilatation of precapillary sphincters, 
but also pulmonary edema in cases of cirrhotic patients. 
Heinemann (1960) proposed the lowered arterial oxygen levels were due 
to venous-to-arterial shunts. He observed that administration of 100% 
oxygen to patients with liver disease experiencing hypoxemia did not 
abolish the problem of hypoxemia. 
' 
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Effects of Portal-Systemic Anastomoses 
Cirrhosis of the liver is accompanied by m~rked changes in the 
hepatic an4 splanchnic vasculature. This· leads to reduced hepatic blood 
flow, increased portal venous pressure, and the development of collateral 
vessels. The formation of collateral vessels allows portal blood to by-
pass the diseased liver. The·portal blood enters either the inferior vena 
cava through port9-caval shunts or the superior vena cava through porto-
pulmonary shunts (Bradley et al., 1952; Taylor and Myers, 1956; and 
Heinemann, 1960, 1977). 
Calabresi and Abelmann (1957), indicated that lowered arterial oxygen 
tensions may be due to either uneven ventilation-perfusion. relationships 
or to .anatomical shunts bypassing the lungs from the portal vein. They 
demonstrated anatomical shunts created by anastomoses of the portal bed 
with the superior vena cava and pulmonary vein. Their data defined the 
shunts ·as follows: 1) a porto-caval shunt would exist when blood passes 
from the portal vein through the peri-esophageal and the mediastinal or 
azygos veins .to the superior vena cava, and 2) a porto-pulmonary shunt 
would exist when blood passes from the portal vein through the peri-
esophageal and mediastinal veins to the bronchial veins and finally to the 
pulmonary vein. A porto-pulmonary shunt would therefore bypass the lungs 
and result in the lowering of arterial blood oxygen levels (Calabresi and 
Abelmann, 1957). 
Heinemann (1960) supported the findings of Calabrasi and Abelmann 
(1957) by suggesting the volume of porto-pulmonary shunted blood depends 
on the available pressure gradient. Heinemann also suggested that 
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metabolites from the gastrointestinal tract would have direct access to 
the pulmonary arteries via cirrhotic shunted or surgically induced 
anastomoses of the portal vein to the vena cava. He points out that the 
development of cardiac hypertrophy, particularly predominant right ven-
tricular .hypertrophy,. occurs in patients with liver cirrhosis. Since 
cardiac output is elevated in cirrhotic patients, it would account for the 
occurrence of pulmonary hypertension as well as cardiac hypertrophy. How-
ever, Heinemann alludes to the idea that vasoactive substances drained by 
the sp,lanchnic vessels and normally inactivated by the liver could reach 
the pulmonary and systemic circulation via the collateral vessels. 
Shaldon et al. (1961) concluded there was no relationship between 
arterial oxygen unsaturation and porto-pulmonary anastomoses, which is 
contrary to Calabresi and Abelmann (1957) and Heinemann (1960). 
The difference in opinion between Shaldon et al. (1961), and Cala-
bresi and Abelmann (1957) and Heinemann (1960) was further complicated by 
Williams and Abelmann (1963), who measured porto-pulmonary shunt flow in 
one patient as 27% of total portal flow, and also by Nakamura et al. 
(1965), who measured shunt flows in two patients at 11% and 14%. However, 
both Williams and Abelmann and Nakamura et al. agreed on two points: 
1) Arterial oxygen unsaturation is not due to the shunts, which 
supports Shaldon et al. (1961). 
2) The shunts may permit substances from the portal venous bed 
to pass directly into the systemic circulation, thus bypass-
ing the liver and the lungs altogether, which supports 
Heinemann (1960). 
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Porto-Caval Shunts and Hepatic Flow 
The discrepancy· in this review concerning anatomical porto-caval and 
porto-pulmonary shunts and their effects is complicated by the surgical 
treatment for portal hypertension in advanced cases of cirrhosis. In 
cirrhotic patients who are afflicted with either bleeding esophageal 
varices or the buildup of ascitic fluid due to increased pressure in the 
portal vasculature, the treatment is to create a porto-caval shunt. This 
is usually done with either a side-to-side or an end-to-side surgical 
anastomosis of the portal vein to the vena cava. This· results in part or 
all of the portal blood being diverted directly into the systemic vascula-
ture and the portal system undergoes decompression (Shackelford, 1955, 
pp. 677-688). 
Bra<lley et al. (1952, 1953) observed hepatic circulation in cirrhosis 
and saw.that hepatic blood flow decreased during any cirrhotic process. 
They stated that hepatic ischemia and relative tissue hypoxia appear to be 
characteristic stigmas and speculated that changes in hepato-cellular 
oxygen metabolism may reflect some serious derangement of cellular physi-
ology. These changes may be followed by necrobiosis and alteration in the 
tissue and vascular structure of the liver. 
Porto-Caval Shunts and Pulmonary Function 
Cotes et al. (1968) evaluated lung function on three patients who had 
porto-caval anastomoses performed five to six years previously. In ob-
serving dilatation of the precapillary vessels of the lung, however, they 
point out that because the surgery decompresses the portal system, there 
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should be no blood flow through any of the porto-pulmonary shunts which 
may have been present. Cotes et al. proposed precapillary pulmonary 
vasodilatation to be one of the consequences of reduced portal blood flow. 
There was evidence in the three patients for the syndrome of defective gas 
transfer, which is usually accompanied by features suggestive of fibrosing 
alveolitis. They concluded that the surgical technique which prolongs the 
lives of these cirrhotic patients may increase the incidenc.e of further 
pulmonary complications. 
Sallam and Watson (1970) discussed complications arising in the lung 
as a result of micro-thromboemboli originating in the splenic and portal 
veins. They described a porto-caval anastomosis performed on a patient 
diagnosed with Banti's syndrome six years previously. Although pulmonary 
function tests and biopsy of the liver were shown to be normal, there was 
considerable evidence of pulmonary hypertension as seen in X-ray films. 
Sallam and Watson came to no conclusion in this study other than the 
problem was.probably due to a thrombus in the splenoportal system re-
leasing microemboli. 
Senior et al. (1968) conducted pulmonary function studies on four 
patients with hepatic cirrhosis and surgical porto-caval shunts. These 
patients had clinical signs of pulmonary hypertension with cor puimonale 
and normal chests as .evidenced by ECG. and chest X-rays prior to porto-
caval anastomosis. On later examinations, there were marked changes in 
ECG indicative of right ventricular hypertrophy, and in the radiologic 
films which showed evidence of cardiac enlargement and dilatation of the 
main branches of the pulmonary artery. Pulmonary parameters and cardiac 
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outputs were normal while minute alveolar ventilation and pulmonary 
arterial pressure were abnormally elevated. Arterial hemoglobin satura-
tion was reduced (hypoxemia). Necropsy studies on two of these patients 
showed microscopic evidence of thromboemboli in small pulmonary vessels. 
The evidence included intimal thickening, medial hypertrophy, and partial 
occlusion and recanalization of vessel lumens. However, no sources of the 
thromboemboli were found at autopsy. 
Lebrec et al. (1979) observed the same symptoms as Senior et al. 
(1968) in nine patients with similar histories of hepatic cirrhosis and 
surgical porto-caval anastomosis. They concluded that diversion of portal 
venous blood into the inferior or superior vena cava plays a major role in 
the development of-pulmonary hypertension. Lebrec et al. suggested a 
vasoconstrictive-agent produced in the splanchnic territory could bypass 
the liver and gain access to the pulmonary arteries, thus inducing 
pulmonary hypertension. 
Johnson and Lambert (1967) studied changes in cardiac output in 
normal dogs that were given end-to-side porto-caval anastomosis. Mor-
tality rate was 50% due to factors outside of the surgery and its conse-
quences. Of the survivors, mean cardiac output was shown to increase 35%. 
They proposed that the increase in cardiac output was the result of a 
cyclic pattern in which portal blood flows into a low resistance system 
(i.e., the inferior vena cava) through the shunt. This results in an in-
creased arterial inflow to the portal system, increasing total portal flow 
which increases venous return. Increased venous return results in a 
greater stroke volume and hence, an increased cardiac output. However, 
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Johnson and Lambert observed a decrease in blood pressure and no change in 
pulse rate or right atrial pressure. 
In summary, this literature review has suggested that alcoholism and 
the resulting cirrhosis causes numerous complications in lung, heart and 
liver. Pulmonary hypertension, increased cardiac output, and decreased 
hepat:Lc blood flow are the major effec.ts of cirrhosis of the liver. How-
ever, it remains difficult to separate the effects of cirrhosis and 
alcoholism from the effects of the clinical treatment for the resultant 
portal hypertension: the porto-caval shunt. 
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MATERIALS AND METHODS 
Surgical Preparation 
Six normal, healthy adult mongrel dogs ranging in weight from 13.6-
22. 7 kg were obtained and housed at Laboratory Animal Resources, Iowa 
State University. Porto-caval anastomoses were created surgically using 
the ,technique for the straight Eck fistula previously described by 
Markowitz, Archibald, and Downie (1964, pp. 542-546). The procedure for 
the Eck fistula is detailed in Appendix A. This surgery created a 1-2 cm 
fistula between the portal vein and the vena cava just above the splenic 
vein in each dog. This allowed portal blood to bypass the liver and gain 
access to the lung vasculature. 
No major problems were associated with each approximately six hour 
surgery and each dog was up and walking twelve to eighteen hours after 
surgery. Only one dog, #1656, experienced a post-operative localized skin 
infection from suture. Antibiotic treatment effectively controlled the 
infection. 
Dog #1582 was used only to test the surgical procedure and was not 
subjected to pulmonary function testing but was included in histopatholog-
ical examinations at termination. 
Pulmonary Function Tests 
D?gs #1588, 1598, 1656, 1704, and 1740 were treated similarly in all 
pulmonary measurements. While under SuritalR (Parke-Davis and Company, 
Detroit, Michigan) anesthesia (22 mg/kg), the animals were intubated and 
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placed in dorsal recumbency. A SO cm 7-French catheter imbedded into a 
rubber stomach tube was filled with normal sali~e and was then inserted 
into the esophagous to about mid-thorax. The animal was then connected 
via the endotracheal tube to a FleischR #0 pneumotach (Instrumentation 
R Associates, Inc., New York, New York) which was attached to a Statham 
PMS differential pressure transducer (Statham Laboratories, Inc., Hato 
Rey, Puerto Rico) for measurement of airflow. Volumes were determined by 
electronic integration and all measurements of flow, volume, and esopha-
R 
geal pressure were measured on a four-channel Beckman R611 Dynagraph 
(Beckman Instruments, Inc., Schiller Park, Illinois). All channels were 
balanced and calibrated before measurements. The esophageal cannula was 
connected to a Statham PR23 low-pressure transducer and after flushing 
with normal saline, the position of the esophageal cannula was adjusted to 
give a slight positive peak at the onset of expiration. After the animal 
and physiological recordings were stable,' a continuous recording (2S mm/ 
sec) for one minute was obtained. Compliance (C) and resistance (R) 
values were then determined. 
Functional residual capacity (FRC) measurements were conducted using 
a multiple breath nitrogen washout method. The dogs were attached to a 
R digital nitrogen analyzer (Hewlett-Packard ll47302A, Hewlett-Packard, 
Inc., Palo Alto, California) and a digital pneumotach (Hewlett-PackardR 
ll47303A). Values for nitrogen content and inspired tidal volume were 
taken from the analog outputs of both devices and recorded on a two-
channel BrushR 220 recorder (Gould, Inc., Cleveland, Ohio). When the 
pattern of respirations appeared stable, the animal was changed from 
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breathing room air to 100% oxygen. At the same time, expired air was 
collected in an evacuated meterological balloon. When the expired nitro-
gen content fell below 10% in each breath, the animal was removed from the 
pneumbtach and the nitrogen content of the expired air in the balloon was 
determined with the nitrogen analyzer. Two separate FRC measurements were 
performed and the results were averaged. 
Samples for blood gas determination were drawn when the nitrogen con-
tent. returned to normal, allowing.the blood to re-equilibrate after FRC 
measurement. Blood gases were measured on an Instrumentation Labora-
toriesR 513 blood gas analyzer (Instrumentation Laboratories, Lexington, 
Maryland) and values for pH, partial pressure of carbon dioxide (Pco2), 
and partial pressure of oxygen (P02) were obtained. The arterial blood 
was sampled from either the right or left femoral artery and the venous 
blood was sampled from either the right or left cephalic vein. 
Liver Function Tests 
The function of the liver was determined 'by injection of a calculated 
amount of sterile indocyanine green (Cardio GreenR, Hynson, Westcott, and 
Dunning, Baltimore, Maryland) and observing the clearance of the dye from 
the blood over a time period of twenty minutes. 
Each animal was restrained, but not anesthetized, and a 20-gauge 
3.8 cm intravenous catheter (IV) was introduced into the cephalic vein. 
After withdrawing a 10 ml zero-time sample, an amount of the dye equiva-
lent to 0.5 mg/kg was injected through a 20-gauge needle into the opposite 
cephalic vein. A timer was started immediately upon injection of the dye 
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and blood samples were withdrawn through the intravenous (IV) catheter at 
times of 1, 5, 10, 15, and 20 minutes post-injection. Blood samples were 
then added immediately to test tubes containing 0.1 ml of 1% (1 g/100 ml 
saline) heparin, and were centrifuged at maximum speed in a clinical 
centrifuge for ten minutes. After the plasma was removed from the packed 
cells, the amount of indocyanine green in the plasma was determined 
spectrophotometrically_at 805 nm and calculated from a standard curve. If 
the absorbance was greater than 0.8, dilutions were made to increase the 
accuracy of the determination. In most cases, no more than a 1:3 dilution 
was required. The clearance curves for t)le dye were then produced by 
plotting on a semi-logarithmic scale concentration (mg/100 ml) vs. time for 
each dog. The clearance curves were subjected to a linear regression 
program and a correlation coefficient was determined to verify the 
linearity of the clearance relationship. F~ve experimental and two normal 
dogs were tested on two separate occasions. 
Clinical Tests 
Blood samples were drawn four days prior to euthanasia and analyzed 
by the Clinical Laboratory, Department of Veterinary Pathology, Iowa 
State University. The levels of blood urea nitrogen (BUN), glucose, 
bilirubin, albumin, alanine amino transferase (~SGPT)., and alkaline phos-
phatase were assayed with the assistance of Dr. A. E. Ledet, Department of 
Veterinary Pathology, Iowa State University. The clinical tests listed 
were selected in order to obtain information which might indicate liver 
abnormality. 
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Ameasurement of activated clotting time (ACT) was also made using 
Vaccu-TainerR #3865 tubes (Becton-Dickinson and Company, Rutherford, New 
Jersey). Elevated clotting time would give an indication of abnormal 
liver function at the cellular level since the majority' of the clotting 
proteins are synthesized by the liver (White et al., 1973, Chapter 30). 
Post-Mortem 
Animals were euthanized at an average of 32 weeks from the time of 
pre-surgical measurements. Samples of brain, lung, heart, liver, 
jejeunum, kidney, spleen, thyroid, and parathyroid weresectionedand 
' ' 
examined by Dr. Robert Glock, Department of Veterinary Pathology, and Dr. 
John Andrews, Diagnostic Laboratory, College of Veterinary Medicine, Iowa 
State University. The portal vein and vena cava in the vicinity of the 
shunt were ligated and removed in order to establish the amount of 
patency in the shunt. 
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CALCULATIONS 
Lung Compliance, Resistance, and Functional Residual Capacity 
Lung compliance and resistance are calculated from values for air-
flow, tidal volume, and esophageal pressure (Figure 1). A perpendicular 
line is drawo through the recordings at zero airflow and at maximum air~ 
flow. When the airflow is zero, there is no effort required by the lung 
to overcome airway resistance and, therefore, the tidal volume and 
esophageal pressure are due only to the elastic resistance of the lung at 
that point. Consequently, compliance can then be calculated using the 
tidal volume (VT) and the esophageal pressure (PT) at zero airflow: 
Compliance (C ) = V /P 
L T T 
From the perpendicular line drawo at maximum airflow, a tidal volume 
at ·a flow (VTF), a pressure at a flow (PTF) and the value for the flow (F) 
are determined. Assuming lung compliance is constant over the range of 
tidal volumes, the esophageal pressure required to overcome elasti.c re-
sistance (compliance pressure) at a given lung volume may be calculated: 
This pressure is subtracted from the total esophageal pressure meas-
ured at an airflow to yield the pressure generated to overcome airway 
resistance to airflow: 
Resistance pressure (P ) = P - P 
R F CL 
The resistance of the airways to airflow is calculated from the re-
sistance pressure and the measured flow (F): 
Resistance (R) = P /F 
R 
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.... 500 
... 
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Figure 1. Recording used to calculate lung compliance (CL) and airway 
resistance (R) · (Engwall, 1980) 
F = maximum airflow 
VT = maximum tidal volume 
VTF = tidal volume at maximum airflow 
PT = esophageal pressure at maximum tidal volume 
PF = esophageal pressure at maximum airflow 
B = baseline 
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FRC was calculated from the following.formula (Figure Z): 
FRC (ml) 
where VE = volume of expired air during washout (ml) 
VDS = dead space of the apparatus (about 45 ml) 
FE = content of nitrogen in the expired air 
FI = content of nitrogen in the inspired oxygen 
F = 0 content of nitrogen in the alveoli pre-washout 
FA= content of nitrogen in the alveoli post-washout 
Since lung compliance and resistance can be affected by the frequency 
of respiration, all values have been normalized by dividing by the fre-
quency. Since FRC is affected by body weight, those values were corrected 
by d;J.viding by the individual weights. 
Liver Function 
From the clearance curves for indocyanine green, the percentage 
disappearance rate was calculated using the following formula: 
Percentage Disappearance Rate (PDR) = (1 -
D = (Ln CZ - Ln c1)/(Tz - T1) 
where c
1 
= concentration at time T1 (mg/100 ml) 
CZ concentration at time T z (mg/100 ml) 
D e ) x 100 
R All calculations were performed on a programmable TI-55 calculator 
(Texas. Instruments, .Incorporated, Dallas, Texas). Programs for the cal-
culation of C, R, FRC, and PDR are detailed in Appendix B. 
Figure 2. Recording used for calculation of functional residual 
capacity (FRC) (Engwall, 1980) 
A. Nitrogen content 
FA = content of nitrogen in the alveoli at the end of 
the washout 
FE = content of nitrogen in collected expired air 
Fr = content of nitrogen in inspired oxygen 
Fo = content of nitrogen in the alveoli at the onset of 
of the washout 
Z = zero line 
B. Expired volume 
VE = total volume of air expired during the washout 
Z = zero line 
n 
8 
·-Z-
-z-
A 
3 :I: 
-09-
-·00~--
Ol 
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Statistical data were provided by the SAS computer system, Iowa State 
University, with the assistance of D. J. Meerdink, Department of Nutri-
tional Physiology, Iowa State University. 
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RESULTS 
Pulmonary Function 
Results of the pulmonary function tests performed on the five dogs 
are listed in Table 1. Measurements ·of compliance (C), resistance (R), 
and functional residual capacity (FRC) were performed on all dogs at 
selected times during the experimental period. 
Control values are designated in period 1 for all measurements. They 
are within the limits determined in our laboratory for normal dogs and are 
also within the range reported by Engwall (1980). 
Four of the five dogs studied showed 66.6% decreases in compliance in 
the first 10-12 weeks after surgery. Three of those four then returned to 
control in subsequent weeks. The fifth dog showed a 26.5% increase in 
compliance which then decreased to approach the control value by the 18th 
week. 
Three of the five dogs exhibited a 46.3% increase in resistance 
during the first 10-12 weeks but subsequently returned to control levels. 
The ,other two. dogs showed 42.5% decreases in resistance in the first eight 
weeks, followed by sharp increases averaging 100% in the next two weeks, 
and then subsequent return toward normal by the 18th week. 
Functional residual capacity (FRC) increased 16 .. 3% in four dogs and 
decreased 25.8% in one dog during the initial 10-12 weeks. However, no 
dog returned to normal values and FRC remained either elevated or de-
pressed at termination. 
Table 1. Pulmonary function data 
Compli- X+ Resist- X± FRC/ X± Mean Mean 
Period a Dog II ance/fb S. E;M. ance/fC S .E .M. ll.w.d S.E.M .. Po2e PCOze mean pH.e 
I 1588 0.0049 1.15 45.0 
(0) 1598 0.0119 0.38 51.2 
1656 0.0079 0.0117 0.41 0.91 59.0 50.2 85.9 48.1 7.342 
1704 0.0160 ±0.0024 1.66 ±0.24 53.9 ±3.0 ±21.4 ±2. 9 ±0.044 
1740 0.0179 0.96 42.1 
II 1588 0.0131 0.97 40.6 
(7. 8) 1598 0.0068 0.0080 0.19 0.81 47.8 54.4 
1656 0.0039 ±0.0019 0.84 ±0.22 65.7 ±5.3 104.9 41.5 7.394 
1704 0.0343 1.08 67.8 ±8.5 ±13.4 ±0.091 
1740 0.0083 1.22 50.3 
III 1588 0.0062 1.41 33.4 N ..., 
(9. 8) 1598 0.0041 0.0047 1.05 1.31 58.6 54.3 
1656 0.0032 ±0.0006 1.39 ±0.23 62.9 ±5.5 99.1 46.0 7.361 
1704 0.0060 2.05 63.3 ±7.5 ±6.2 0.019 
1740 0.0038 0.65 53.4 
~ean time (weeks) after surgery. 
b 
L/cm•HzO/bpm. 
c 
cm H20/L/sec/bpm. 
d ml/kg. 
e+l S - .D. 
Table 1. (Continued) 
Compli- Resist- X± FRC/ X± Mean Mean 
Period Dog II ance/f X±S.E.M. ance/f S. E .M. B,W. S.E.M. P02 PC02 mean pH 
IV 1588 0.0051 0.36 31.8 
(17.8) 1598 0.0104 0.0098 o. 36 0.83 46.0 57.2 
91.6f 43.2f 7.410f 1656 0.0029 ±0.0026 0.39 ±0.28 64.0 ±8.5 
1704 0.0163 1.54 81.3 ±12.7 ±5.4 ±0.016 
1740 0.0145 1.51 62.9 
v 1588 0.0050 1.09 28.2 
(31. 8) 1598 0.0106 0.0096 0.35 0.93 75.5 60.1 
1656 0.0031 ±0.0026 0.60 ±0.21 51.9 ±9.6 90.5 41.6 7.370 
1704 . 0.0176 1. 56 82.8 ±8.3 ±3.4 ±0 .. 048 
1740 0.0118 1.04 62.1 
N 
f 
..,. 
n = 4. 
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Since the surgical procedure on all five dogs was not performed on 
the.same day, the time of pulmonary function measurements after surgery 
was variable for each dog. Therefore, the times of measurement from the 
initial were averaged along with the individual measurements of C, R, and 
FRC to aid in the statistical evaluation. By averaging these data, the 
time after surgery was· condensed into five periods and the means and 
standard error were calculated. 
There was a significant decrease (P < 0.05) in compliance (Figure 3) 
from the control for all five dogs. This was accompanied by a concurrent 
significant increase (P < 0.05) in resistance (Figure 4). The mean FRC 
showed an increasing trend overall, but the increase was not significant 
(Figure 5). 
The changes in mean arterial oxygen content (P02), carbon dioxide 
(PC02), and pH were not significantly different from the control. 
Liver Function Tests 
The res.ults from the liver function tests including percentage dis-
appearance rate and correlation coefficients from the clearance curves are 
given ~n Table 2. The data for analysis 1 were obtained at an average of 
19 weeks after surgery for all animals. The percentage disappearance rate 
for each animal during both liver function analyses shows no significant 
difference between the first and second analysis,. which was made seven 
weeks later at an' average of 26 weeks after surgery. 
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Figure 3. Mean compliance vs. mean time post-op; compliance·values are 
averages for five dogs and are plotted against time periods; 
the change between period 1 (control) and period 3 is sig-
nificant (P < 0.05) 
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Figure 4. Mean resistance·vs. mean time post-op; resistance values are 
averages for five dogs and are plotted against time periods; 
the change between period 1 (control) and period 3 is sig-
nificant (P < 0.05) 
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Figure 5. Mean functional residual capacity (FRC) vs. mean time post-op; 
FRC values are averages for five dogs and are plotted against 
time periods 
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Table 2. Results of liver function analysis - percentage disappearance 
rate (PDR) 
Analysis la Analysis 2 
b 
Dog II PDR Corr. coeff.. PDR Corr. Coeff. Remarks 
1588 6.1 -1. oooc 9.7 -1.000 Shunted 
1598 8.6 -1. 000 9.2 -0.983 Shunted 
1656 10.5 -1. 000 12.5 -0.965 Shunted 
1704 8.2 -0. 945 4.1 -0.994 Shunted 
1740 10.6 -0.993 8.2 -0.982 Shunted 
1712 8.6 -0.993 Normal 
1778 13.4 -0.961 Normal 
a 
19 weeks Performed at an average post-op. 
b Performed at an average 26 weeks post-op. 
c 
. -1 = perfect correlation. 
Clinical Tests 
The results of the clinical blood analyses including the activated 
coagulation times (ACT) for all five dogs are displayed in Appendix C. 
All values were normal at termination. 
Post-Mortem Observations 
Post-mortem examination results for all· six surgical an~mals indicate 
that all animals demonstrated mild to moderate right heart dilatation. 
Two of the dogs showed mild congestion in the lung, and four dogs showed 
congestion in the liver (Appendix D). Although three dogs showed signs of 
hookworm infestation, all other structures appeared normal in each dog. 
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Gross examination of the portal vein and vena cava in the vicii;iity of the 
shunt revealed a nonpatent shunt in all dogs. Judging by the condition of 
the vessels, the shunt had been closed for some time. 
Histop_athological examination revealed all ~nimals to have varying 
degrees of fibrosis and congestion in the liver, and also varying degrees 
of interstitial thickening, fibrosis, and congestion in the lungs. Most 
other sections showed no major lesions. 
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DISCUSSION 
The Fate of the Shunt 
At termination of the experiment that the shunts were closed and 
apparently had been nonfunctional for some time. This finding immediately 
ruled out the major assumption made at the beginning of this project. The 
assumption the shunts would remain patent indefinitely was based on 
two reasons: 1) the pressure gradient between the portal vein and the 
vena cava would increase blood flow through shunt; and 2) since the vena 
cava is a lower resist~nce system than the liver, there would be a tenden-
cy for blood flow to pass through shunt. From these experimental data, 
the two reasons appear valid for only the first ten weeks after surgery. 
In preliminary research by the author, the portal pressure at the 
level of the splenic vein in one normal dog was 8 mmHg. Taylor and Myers 
(1956) found portal pressures in normal cats to range from 5-13 mmHg with 
a mean pressure of 8 mmHg. The pressure in the.vena cava at the level of 
the liver is 2 mmHg (Swenson, 1977, p. 135). Therefore, the pressure dif-
ference between the two vessels could be predicted to be 6 mmHg. 
If the portal vein had been ligated as outlined in the original pro-
cedure (Mar~owitz et al., 1964), there is no doubt patency wo.uld have been 
maintained. However, the complications from a complete shunt may have 
been a.greater problem. Markowitz et al. described in detail the, symptoms 
of meat intoxication in dogs with complete Eck fistulas. They noted re-
curri?g instances of coma and lethargy in shunted dogs. Johnson and 
Lambert (1967) ·reported similar problems in their dogs. They reported 
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losing 50% of their animals due to the same complications described by 
Markowitz et al. 
Because the portal vein was not ligated, the problems reported by , 
Markowitz et al. (1964) and Johnson and Lambert (1967) were not experi-
enced in this project. The liver was able to receive some portal blood. 
The apparent reason for shunt failure can be attributed to not 
ligating' the portal vein and possibly the method for producing the shunt. 
The cut edges of the vessel walls would have provided enough connective 
tissue surface that platelets and fibrin strands could have been laid' down 
immediately following surgery. Since the predicted pressure difference 
was small, it r.emains doubtful the shunt flow 'Would have been enough to 
prevent further deposition of material in the shunt. Therefore, the shunt 
would gradually become sealed over time. 
Pulmonary Studies 
Although the fistula failed, there was still a marked change observed 
in both pulmonary structure and function. In all dogs subjected to 
pulmonary studies, the maximum change in compliance and resistance values 
occurred at an average of ten, weeks after surgery (period 3). After ten 
weeks post-surgery, complianc~ and' resistance values approached, pre-
surgery levels. Although a positive correlation cannot be made, the re-
turn of pulmonary measurements to normal may indicate the closure of the 
shunt. Functional residual capacity (FRC) increased slightly. These 
changes can be explained by the microscopic structural changes in the 
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lung. There were marked signs of interstitial thickening and pulmonary 
edema accompanied by varying degrees of fibrosis in the dog lungs. 
In cases of pulmonary edema, compliance decreases due to reduction in 
lung volume and interference with the elastic properties in the lung. 
'concurrently, lung resistance increases due to the narrowing of the·small 
airways as a result of the thickening of the peribronchial cuff. FRC 
usually increases when there is an increase in airway resistance. The 
presence of fibrotic areas would also tend to decrease compliance, but 
resistance and FRC would tend to either remain normal or decrease sli.ghtly 
(West, 1977). 
·The changes observ,ed in compliance, resistance, and FRC may be due to 
not only interstitial edema.but also to the presence of microemboli, which 
were most prominant in ·dog 111582. Microemboli could play a P'.irt· in ·:·t~e.··· 
development of pulmonary hypertension (Sallam and Watson, 1970). '.!;here · 
was considerable right heart dilatation observed in all dogs which may 
have been produced by pulmonary hypertension. The various factors that 
lead to pulmonary hypertension include obliteration of the capillary bed 
by destruction of alveolar walls or interstitial fibrosis, and hypertrophy 
of smooth muscle in the walls of small arteri~s (West, 1977). All dogs 
demonstrated areas of tissue degeneration and fibrosis in the lung. Dr. 
Andrews of the Diagnostic Laboratory, Iowa State University, observed that the 
severity of tissue abnormality in the dogs of this project was correlated 
to the amount of time passed since surgery was performed. 
The literature reported the same findings as this research, only 
under much different circumstances. The four patient studies by Senior 
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et al. (1968) demonstrated marked changes in anatomical structure of heart 
and lungs after surgery for porto-caval anastomosis. Prior to surgery, 
these patients had liver cirrhosis and portal hypertension. However, 
after surgery, pulmonary hypertension and cor pulmonale was noted. 
In patients with liver cirrhosis, Lebrec et al. (1979) agreed with 
Senior et al. (1968) that the existence of pulmonary emboli was the cause 
of the pulmonary hypertension. However, neither Lebrec et al. or Senior 
et al. could find the source of the emboli at autopsy. 
Since no gross thrombi were found in this project, the pulmonary and 
cardiac abnormalities that were observed are more related to the porto-
caval anastomosis than to the liver damage. Unlike the studies by Lebrec 
et al. (1979) and Senior et al. (1968), all dogs used in this project were 
normal, healthy dogs. There were no symptoms or direct evidence of liver 
cirrhosis, portal hypertension, excessive alcohol intake, smoking, or 
other problems that were experienced by Lebrec et al. or Senior et al. 
The.gross and microscopic abnormalities produced by the shunt in the dogs 
in this project were still apparent at termination 22 weeks later. 
Because the shunt may be responsible for the changes in pulmonary 
function instead of the liver, the following question arises, "What com-
pound is contained in portal blood that would produce these changes?" In 
normal systemic circulation, compounds that would be normally detoxified 
by the liver could cause either the destruction of lung tissue or the for-
mation of microemboli. Both Lebrec et al. (1979) and Heinemann (1960, 
1977) have proposed the existence of agents from the splanchnic or mesen-
teric vasculature passing through the shunt into the general circulation. 
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There are several possibilities for the nature of this agent: 
1) Microemboli that would form normally in the walls of the intestine 
could reach the lung parenchyma directly through the shunt. 
2) Bacterial cells (particularly anaerobes) that gain access to the 
portal vein from the intestine could exhibit a thrombogenic or 
vasoconstrictive response when trapped by the lung capillaries. 
The cell-mediated immune system could cause an edematous response 
in removing these bacterial cells. 
3) Endotoxins from these bacterial cells could exhibit a hypertensive 
response. 
4) The circulating levels of digestion products would become ab-
normally elevated in the lung capillaries. Particularly, the 
concentrations of amino acids and fatty acids after a meal would 
require an increased time to be cleared from the general circula-
tion. This may be enough to cause trauma to the lung vasculature. 
Any of the four possibilities mentioned could be responsible for 
causing the pulmonary hypertension. These suggestions remove the major 
emphasis from the liver as being the causitive agent responsible for 
changes in the lung. 
Liver Function Studies 
All the values for percentage disappearance rate (PDR) are within the 
range for normal dogs reported by Wheeler et al. (1958). These PDR values 
are also in agreement with values calculated from data reported by Stekiel 
et al. (1960). Tests were within the range established by the clinical 
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laboratory, Iowa State University. It should be noted that in some of the 
measurements, .the values are approaching the limits of normality. The 
activated coagulation time (ACT) results were within the normal range re-
ported by Byars et al. (1976). 
The function of the liver as determined by dye clearance methods 
allowed the cellular function of the liver to be measured. It would also 
have allowed information relating to the patency of the shunt to be ob-
tained. However, the dye clearance determinations were performed after 
the shunt had probably closed. Stekiel et al. (1960) and Banaszak et al. 
(1960) reported a method to calculate mean hepatic transit time using indo-
cyanine green in dogs. The method required hepatic cannulation with the 
assistance of a fluoroscope. and only total hepatic flow, not portal flow, 
could be established. Therefore, no simple noninvasive technique is avail-
able to measure portal flow or shunt flow without performing lapai:otomy. 
Although liver function was normal at termination, the liver was 
apparently affected by the presence of the shunt. Histological examination 
revealed a marked disorganization in the liver parenchyma and an overall 
fibrosis of the central veins in all dogs. Bradley et al. (1952, 1953) 
' 
observed similar chan!les in cirrhotic livers in humans. Hepatic ischemia 
and tissue hypoxia are common in the cirrhotic process, and these factors 
were observed ·in this research. The cellular abnormalities observed in 
the dogs in this project suggests serious results when portal blood flow 
is reduced. The liver of the dog is highly dependent on portal blood for 
oxygen (Swenson, 1977, p. 135). 
The values reported for the clinical tests were within the range 
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established by the clinical laboratory, Iowa State University. It should 
be noted that in some of the measurements, the values are approaching the 
limits of normality. The activated coagulation time (ACT) results were 
within the normal range reported by Byars et al·. (1976). 
Mathematical Model 
A mathematical model of the liver and the shunt was developed to 
characterize the flow patterns around the liver. The liver was treated as 
a single pool with two inputs and one output. Output from the lymphatic 
vessels of the liver is very small and was omitted. Two first-order dif-
ferential equations. were determined for both cases (normal and shunted) 
and their derivations are given in Appendix E. The resulting equations 
were programmed on a PDP-SA computer (Digital Equipment Corporation, 
Maynard, Massachusetts) and the results were displayed on a storage os-
cilloscope. Figure 6 demonstrates both the normal and shunted hepatic 
·clearance of a liver-specific dye (e.g., indocyanine green). As the 
shunt diverts increasing amounts of blood away from the portal vein, the 
ability of the liver to remove the dye from the general circulation becomes 
lessened and .the clearance time increases. When the ratio of normal half-
time (T~) to shunted half-time (T'~) was calculated, a relationship was 
established relating this ratio to the product of the shunt fraction (o) 
and the ratio of total hepatic venous flow (QL) to the hepatic arterial 
flow (QH): 
T~ QL 
T\ = o QH 
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From this relationship, the shunt fraction may be calculated if the 
half-time ratio and the liver flow ratio is known. Therefore, a nonin-
vasive technique may be available to determine the amount of shunt in an 
animal. 
Figure 6. Computer simulated clearance of indocyanine green; the photo-
graph was constructed by the PDP-SA computer using the developed 
equations. The Y-axis represents concentration and the X-axis 
represents time. The graph shows predicted change in clearance 
of the dye. The bottom curve represents 0% shunt while the 
curves above represent 25, 50, 75, and 100% shunt respectively. 
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CONCLUSIONS AND RECOMMENDATIONS 
In reviewing this research project, there is no doubt regarding the 
importance of maintaining a patent shunt. The results (or lack of re-
sults) obtained depended on a patent shunt at termination. More knowledge 
concerning the function of the shunt has been obtained and future experi-
ments will be based on this knowledge. 
An incomplete shunt (portal vein intact) appears to be patent for 
only ten weeks. Therefore, a more concentrated study must be devoted to 
the early period of.patency. 
A complete shunt (portal vein ligated) or implanted static shunts may 
be necessary to maintain the patency of the shunt and produce the maximum 
change in pulmonary and liver function. However, the complications asso-
ciated with portal ligation would cause adverse conditions that would 
affect collection of reliable data. Furthermore, there are no cases re-
ported of a complete anatomical shunt. Therefore, the complete shunt 
would not be an accurate model for the cirrhotic condition. 
More data must be collected if changes in pulmonary and liver func~ 
tion are to be more accurately described. This will require more animals 
and more frequent pulmonary and liver function, and clinical tests. This 
will hopefully eliminate any possible questions regarding events occurring 
between long periods of time, which was a problem in this research. 
Finally, .the mathematical model must be expanded and confirmed by 
animal experimentation. With the aid of thi!i model, a noninvasive method 
to determine the shunt fraction from dye clearance data can be improved 
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and tested. The model would enable the researcher to obtain information 
regarding the dynamics of a porto-caval shunt without resorting to 
surgical laparotomy. 
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SUMMARY 
Five normal dogs were given porto-caval shunts using a modified tech-
nique of the Eck fistula. Measurements of pulmonary function including 
compliance, resistance, and functional residual capacity, and arterial 
oxygen· levels demonstrated significant decreases in compliance and in-
creases in resistance. Functional residual capacity and arterial oxygen 
levels did not change significantly. Liver function determined by 
clearance of indocyanine green and clinical blood tests including blood 
urea nitrogen, glucose, bilirubin, albumin, SGPT, and alkaline phosphatase 
were normal at termination. There was marked right heart dilatation in 
all dogs. Histologically, the lung demonstrated considerable edema and 
interstitial thickening in all dogs. The liver showed mild to moderate 
ischemia and fibrosis. A mathematical model simulating dye clearance in 
both normal and shunted animals demonstrated increased clearance time in 
the shunted animal. 
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APPENDIX A: SURGICAL PROCEDURE 
The following is a detailed description of the methods used to create 
a porto-caval shunt from the procedure for performing an Eck fistula, as 
described by Markowitz et al. (1964, pp. 542-546). 
After fasting 24 hours, each dog was anesthetized with sodium pento-
barbital (28.6 mg/kg). The animal was then intubated and prepared for 
surgery by shaving hair from dorsal to ventral midline on the right side 
extending from mid-thorax to the hind limb. Following preparation of the 
surgical site asceptically, the animal was placed on the table in dorsal 
recumbency with exposure favoring the lateral right side. The table was 
equipped with a circulating heating water pad to control body temperature 
during the procedure. 
The incision was made starting from the xiphoid process down the 
midline for approximately 4 cm, then down at an angle paralleling the 
costal margin to just beyond the nipple line, extending to about the level 
of the umbilicus. Stay sutures were placed on the muscle groups to be in-
cised to aid in alignment on closure and care was taken to control bleed-
ing as the Rectus abdominus, internal abdominal oblique, a section of the 
external abdominal oblique, and the Transversus abdominus were cut. Upon 
entering the peritoneum, the incision was retracted and after wrapping the 
viscera in the mesenteric membrane, the viscera were removed from the 
cavity and placed in a moist, sterile turkish towel and placed to the left 
side of the animal. 
After stripping fat and overlying fascia away from both portal vein 
and vena cava, stay sutures were placed (Figure 7) using 5-0 cardio-
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Figure 7.. The Eck fistula; the portal vein (right) has been .att:a.ched tp 
the vena cava (left) by stay sutures (arrows) a!ld the posterior · 
suture line is laid with the bottom needle. (Markowitz eLal.·, 
1964, p. 550, figure XXVIII-25) ' ., ' , 
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vascular si~k to attach the two vessels together. Two needles were used 
for the two stay sutures and the needles were left intact for the next 
step. 
A posterior suture line was then placed continuously between the two 
vessels using a length of 5-0 silk distal to the liver. Care was taken to 
control bleeding as the needle was passed through the portal wall, as the 
wall is very thin and tears quite easily. 
Upon completion of the posterior suture line, a cutting thread of 
1-0 gastrointestinal silk was then placed in both vessels near and paral-
lel to the suture line (Figure 8a). 
After the cutting· thread was placed, the 5-0 silk proximal to the 
liver was used to place the anterior suture line in the same manner as 
before (Figure 8B). When completed, the two vessels are aligned (Figure 
8C) with the cutting thread buried between them. 
The cutting thread was carefully pulled free in a back-and-forth 
motion, cutting the walls of both vessels and creating the fistula in the 
process. In some cases, there was some bleeding from the exit point of 
the cutting thread which was controlled by placing a single interrupted 
suture of 5-0 silk to further close the exit point. 
Once it was certain hemostasis had been achieved, the viscera were 
replaced, the retractor removed, and the incision was closed using 3-0 
silk in a continuous pattern, taking care to align the layers of muscle 
and fascia. The skin was closed using VetafilR (S. Jackson, Inc., 
Washington, DC) in a single.interrupted pattern. 
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c. 
A. B. 
Figure 8. The Eck fistula; the portal vein is on the right and the vena 
cava is on the left. A) The cutting thread is introduced 
parallel to the posterior suture line. This thread will create 
the fistula when pulled free. B) The anterior suture line 
draws both vessels together and buries the cutting thread be-
tween the two vessels. C) Principle of action of the cutting 
thread. The vessels are aligned as shown in cross-section. 
Pulling the cutting thread free will complete the fistula. 
(Markowitz et al., 1964, p. 551, figure XXVIII-26) 
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The technique described above was slightly modified from the original 
description (Markowitz et al., 1964) in that the portal vein was not 
ligated following completion of the fistula. The author felt this would 
simulate the actual conditions of advanced liver disease more closely than 
a complete shunt. 
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APPENDIX B: CALCULATION PROGRAMS FOR TI-55 CALCULATOR 
Compliance-Resistance Program 
Key stroke Step Key code Key stroke Step Key code 
RCL 00 61 = 16 85 
2 01 02 + 17 45 
+ 02 45 RCL 18 61 
RCL 03 61 0 19 00 
4 04 04 = 20 85 
05 85 R/S 21 86 
R/S 06 86 RST 22 87 
l/X 07 34 23 00 
x 08 55 24 00 
RCL 09 61 25 00 
1 10 01 26 00 
= 11 85 27 00 
+/- 12 84 28 00 
+ 13 75 29 00 
RCL 14 61 30 00 
3 15 03 31 00 
Memory locations Value for 
STO 0 Flow (F) 
STO 1 Tidal volume at a flow (VTF) 
STO 2 Tidal volume (VT) 
STD 3 Pressure at a flow (PTF) 
STO 4 Esophageal pressure (PT) 
Procedure 
1) Store values from Dynagraph recordings into memory. 
2) Push run (R/S) key - display shows calculated compliance (CL). 
3) Push run key again - display shows calculated resistance (R). 
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Functional Residual Capacity Program 
Key stroke Step Key code Key stroke Step 
STO 00 51 R/S 16 
0 01 00 STO 17 
~y 02 31 1 18 
SUM 03 71 ~y 19 
0 04 00 +/- 20 
·R/S 05 86 SUM 21 
STO 06 51 1 22 
1 07 01 EXC 23 
X:tY 08 31 1 24 
+/- 09 84 l/X 25 
SUM 10 71 PROD 26 
.l 11 01 0 27 
EXC 12 66 RCL 28 
1 13 01 0 29 
PROD 14 76 R/S 30 
0 15 00 RST 31 
Memory locations 0 and 1 are used for temporary purposes. 
Procedure 
1) Enter deadspace volume (VDs> = 45.0. 
2) Push interchange key (~Y). 
3) Enter expired air volume (VE). 
4) Push run (R/S) key - disregard display. 
5) Enter nitrogen content of inspired oxygen (F.1). 
6) Push interchange key. 
7) Enter nitrogen content of expired air (FE). 
8) Push run key - disregard display. 
9) Enter post-was~out alveolar nitrogen content (FA). 
10) Push interchange ~ey .. 
11) Enter pre-washout alveolar nitrogen content (F
0
). 
12) Push run key - display shows calculated FRC. 
Key code 
86 
51 
01 
31 
84 
71 
01 
66 
01 
34 
76 
00 
61 
00 
86 
87 
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Percentage Disappearance Ra~e Program 
Key stroke Step Key code Key stroke Step Key code 
STO 00 51 RCL 16 61 
1 01 01 3 17 03 
X*Y 02 31 = 18 85 
• 03 45 INV 19 21 
RCL 04 61 PROD 20 76 
1 05 01 2 21 02 
= 06 85 RCL 22 61 
lnX 07 23 2 23 02 
STO 08 51 eX 24 24 
2 09 02 +/- 25 84 
R/S 10 86 + 26 75 
STO 11 51 1 27 01 
3 12 03 = 28 85 
Y.;toY 13 31 R/S 29 86 
+/- 14 84 RST 30 87 
+ 15 75 31 00 
Memory locations 1, 2, and 3 are temporary only. 
Procedure 
1) Enter value for c2. 
2) Push interchange key (X.,,Y) • 
3) Enter value for c
1
• 
4) Push run (~/S) key. 
5) Enter value for r
1
. 
6) Push interchange key (Y.;toY). 
7) Enter value for r
2
. 
8) Push run (R/S) key. 
9) Multiply display value by 100. 
10) Display shows calculated percentage disappearance rate. 
' ' 
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APPENDIX C: CLINICAL TEST RESULTS 
Dog II 
Test 1588 1598 1656 1704 1740 
Urea nitrogen (rng/dl) 12 18 18 21 16 
Glucose (mg/dl) 102 75 93 81 89 
To.tal bilirubin (mg/dl) <1.0 <1.0 <1.0 <1.0 <1.0 
Direct bilirubin (mg/dl) <1.0 <1.0 <1.0 <1.0 <1.0 
Albumin (gm/ dl) 3.6 3.3 4.1 3.2 3.0 
SGPT (IU/l) 19.2 15.4 17.5 15.7 62.4 
Alkaline phosphatase (IU/l) 39.7 24.9 28.0 29.0 26.3 
Activated clotted time (sec) 102 115 129 97 96 
\ 
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APPENDIX D: POST-MORTEM OBSERVATIONS 
The following observations were made at termination for the six dogs 
used in this project. Included are gross as well as histopathological 
observations, as determined by Dr. Robert Glock, Department of Veterinary 
Pathotogy, Iowa State University, and Dr. John Andrews, Diagnostic 
Laboratory, College of Veterinary Medicine, Iowa State University. 
Gross Observations 
Observations were made only if organ or tissue had visible signs of 
abnormality. All other normal tissues were not listed. The animal's 
breed, sex, weight, and time since surgery are given. 
Dog #1582: Irish Setter, male, 22.7 kg, 43 weeks. The lung had 
raised grey plaques 1-2 cm on both diaphragmatic lobes and what appeared 
to be pleural thickening. There was moderate right heart dilatation. 
Dog #1588: Husky, female, 25.4 kg, 33 weeks. Hair on right side 
never grew back after surgery and numerous skin lesions were noted. The 
brain had moderate internal hydrocephalus. The liver was 740 gm and 
appeared slightly congested with rounded edges. The heart showed very 
mild right heart dilatation with a calcified plaque on the endocardial 
surface of the right ventricular wall. The kidneys were normal except 
for a surgical sponge adhered to the anterior pole of the right kidney. 
There was a mass of adhesions in the mesentery. 
Dog #1598: Terrier-Hound, female, 16.3 kg, 34 weeks. The left lung 
was mildly congested. The heart showed mild right heart dilatation. The 
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liver was 640 gm and appeared normal. The jejunum showed a moderately 
roughened mucosa due to heavy hookworm infestation. 
Dog #1656: Labrador-Irish Setter, male, 13.2 kg, 33 weeks. The 
heart showed considerable right heart dilatation. The liver was 550 gm 
and was mildly congested. There was still evidence of subcutaneous in-
fection at the suture line with numerous fistulous tracts under the skin. 
Dog #1704: Collie-Mixed, female, 15.9 kg, 29 weeks. The heart 
showed moderate right heart dilatation. The liver was 830 gm and showed 
moderate congestion. There was a mild hookworm infestation. 
Dog #1740: Golden Retriever, male, 17.7 kg, 32 weeks. The heart 
showed very mild right heart dilatation. The liver was 1000 gm and was 
moderately congested. There was thickening of the jejunal mucosa and 
blood spots were evident due to a moderate hookworm infestation. 
Histopathological Observations 
Dog #1582 (Case #8J-R-1142): Time since surgery= 43 weeks. 
Slide Tissue 
A Kidney 
F Kidney 
B,E Liver 
c Lung 
Description 
NML (no major lesions) 
NML 
Centrilobular veins fibrotic and mildly in-
filtrated with mononuclear cells. Hepatic cords 
disorganized and centrilobular hepatocytes 
vacuolated. Diffuse retention of bile in the 
hepatocytes noted. 
Moderate interstitial thickening throughout the 
section. Lesion in one end showed consolidation 
with macrophages and some interstitial fibrosis. 
A few alveoli contained neutrophils. 
G Lung 
D Spleen 
F Thyroid 
E'. Parathyroid 
G Heart 
H Adrenal 
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Moderate interstitial thickening and considerable 
smooth muscle hypertrophy around terminal 
bronchioles. Mild anthracosis noted. 
Moderate lymphoid depletion. 
NML 
NML 
NML 
NML 
Dog #1588 (Case #80-R-1141): Time since surgery= 33 weeks. 
A-D Brain 
E Kidney 
F Lung 
I Lung 
K Lung 
G Liver 
I Liver 
G Spleen 
H Thyroid 
H Parathyroid 
H Jejunum 
J Heart 
L Jejunum 
M Skin 
NML 
NML' 
Moderate congestion and interstitial thickening.· 
Moderately congested. 
NML 
Congested with fibrosis around centrilobular 
veins. 
Congested with fibrosis. 
Congested. 
NML 
NML 
NML 
Adipose cells scattered throughout. An area of 
bone and cartilage on endocardial surface. 
NML 
Marked hyperkeratosis and very thin epithelium. 
Dog #1598 (Case #80-R-1143): Time since surgery= 34 weeks. 
A-D Brain NML 
E Kidney 
F,J,M Liver 
G Lung 
I Lung 
H Jejunum 
I Thyroid 
K Jejunum 
L Heart 
H Lung 
H Thyroid 
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Several very small foci of mononuclear inf lamma-
tory cells. 
Mild diffuse fatty change. Severe fibrosis and 
mononuclear infiltration of central veins. Some 
recanalization present. 
Areas of mild to marked interstitial fibrosis. 
Alveoli contain leukocytes, some of which were 
heart failure cells. 
Mild to moderate interstitial thickening and some 
smooth muscle hypertrophy. 
NML except for one embedded hookworm. 
NML 
NML 
NML 
NML 
NML 
H Parathyroid NML 
I Jejunum 
K Spleen 
L Heart 
Dog 111656 (Case, 
A-C Brain 
D Kidney 
E Liver 
G Liver 
F,J Lung 
NML 
Very congested. 
Adipose cells scattered in myocardium. 
1180-R-1139): Time since surgery = 33 weeks. 
NML 
Congested. 
Congested around central veins and sinusoids. 
Central veins surrounded by fibrin and very early 
fibrosis. Areas of inflammatory cell infiltra-
tion around portal and central vessels. Some of 
these areas contained numerous eosinophils. 
Same as slide E plus some mild fatty change. 
Generalized congestion and focal areas of mild 
interstitial thickening. 
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H Lung NML 
H Thyroid NML 
H Parathyroid NML 
I Jejunum NML 
K Spleen Very congested. 
L Heart Adipose cells scattered in myocardium. 
Dog 111704 (Case l/80-R-1140): Time since surgery ~ 29 weeks. 
A-C Brain NML 
D Kidney Mildly congested. 
E Liver Moderately congested. 
I Liver Moderately congested. 
E,F,J Lung Mildly congested. 
G Heart NML 
G Thyroid NML 
G Parathyroid NML 
H Jejunum NML 
J Lymph Node NML 
K Spleen Congested. 
Dog 111740 (Case l/80-R-1144): Time since surgery 32 weeks 
A-C Brain NML 
D Kidney NML 
E,F,J Liver Marked congestion with edema, fibrin, mono-
nuclear cells, and mild fibrosis around central 
veins. 
G Lung Congestion. 
H Spleen Some dilatation of veins in traveculae. 
I 
K 
L 
L 
Jejunum 
Heart 
Thyroid 
Lymph Node 
NML 
NML 
NML 
NML 
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APPENDIX E: MATHEMATICAL MODEL FOR CLEARANCE OF INDOCYANINE GREEN 
CASE I: no shunt 
rate of destruction in liver -KQC 
KQ = "clearance'' 
Dye in blood 
(1) dC VB dt = (Qm + QH)CL - QHC - ~c 
accum. dye return- dye flow-
in blood ing from ing to 
(neg) liver liver via 
hepatic 
artery 
Overall 
(2) 
Dye 
(3) 
QL = Qm + QH 
in liver 
dCL 
(~ + QH)C -v -= L dt 
accum. in 
liver (neg) 
into 
liver 
(~ + QH)CL 
out of 
liver 
dye flowing 
to liver 
from portal 
vein 
- K(~ + QH)CL 
destruction 
K(~ + QH) = 
liver dye 
clearance 
Solutions: from (1) and (2) - substituting and rearranging 
(4) 
(5) 
(6) 
(7) 
dC 
dt 
from (2) and (3) - substitute and rearrange 
mult. in/out 
VB 
term by V 
B 
CASE II: shunt 
62 
where C(O) = 1 
CL(O) = 0 
a = fraction of blood shunted to vena cava 
p = (1 - a) = fraction of portal blood left after shunt 
a > O, p < 1 
Same eqns. hold except: 
Solutions: 
(9) 
(10) 
(c' - c') L 
When QL is reduced, 
General solution: 
I - no shunt: 
from (5) 
Subst. (8) for 
dCL . 
dt into (11) 
Solving (5) 
for CL 
where 
Q' 
L 
QL = 
CI (0) 1 
CL(O) = 0 
is lengthened, clearance is reduced. 
VB 
v = v• 
L 
KQL 
K=-V , 
L 
take derivative of S 
[ [Y(c - C ) - KCL) - dC) 
T L dt 
(8) 
(11) 
(12) 
(13) 
Subst. (13) into 
(12) for CL 
drop ( ) 
and corn;lense 
rearranging 
to final form 
· general form 
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K(T ~~ + C) l - ~~] (14) 
[ [~ (C - T dC - C) - KT dC - KC] - .!. dC] 
T dt dt T dt 
(15) 
- -
v dC K dC ~ KC _ .!_ dC 
- T dt - dt . T T dt (16) 
-[(v + K + .!_) dC] 
T T dt 
KC --
T 
(17) 
(K + .!. + ~) dC + (~)C = O 
T T dt T 
(18) 
where C(O) 1, ~~ (0) = 1/-r from (5) 
2- -
A d c + B dC + c 'C = 0 
dt2 dt 
(19) 
general solution C(t) -mt De (20) 
first derivative 
.second derivative 
substituting 
(20-22) into 
(19) 
factoring 
and mult. 
l/De-mt 
-mt De 
by 
solving for m 
using quadratic 
eqn . 
. general 
solution 
dC -mt 
dt = -mDe (21) 
·2 
d C = +m2De-mt 
dt2 
(22) 
Am2De-mt - BmD-mt + C'De-mt = 0 (23) 
2 
Am -Bm+C=O (24) 
(25) 
(26) 
from (18) 
from (26) and 
(18) 
simplifying 
from (27) 
substituting 
into (29) 
from (25) 
from (18) and 
(19) 
from (32) , 
multiply by 2 
combining 
similar terms 
and simplifying 
solving for n
1 
simplifying 
solving for n
2 from (30) 
from (18) and 
(19) 
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D = 1 - D 2 1 
(B +/B
2 
- 4AC)
0
D + B - JB
2 
- 4Ac)' 
2A 1 ( 2A 
B -/BZ - 4AC)D 
( 2A 1 l/T 
A = 1 
(B + /B
2 
- 4c)nl + (B - JB2 - 4c) 
- (B - JB
2 
- 4c)nl = 2/T 
(B +JB
2 
- 4C
0 
- B +JB
2 
- 4c)nl 
J 
z . 
+ (B - B - 4C) = 2/T 
c2Jll
2 - 4c)n
1 
+ B - JB
2 
- 4c = 2/T 
J 2 I = 2/T - B +B - 4C 
Dl 
2JB
2 
- 4C 
Dl = l/T(B2 - 4C)-l/ 2 - ~( B2 - 4C)-l/ 2 + 1/2 
D = -1/T (B2 - 4C)-l/ 2 + ~( B2 - 4C)-l/2 + 1/2 
2 2 
B = (K + l/T + v/T) 
C = (K/T) 
(27) 
(28) 
(29) 
(30) 
(31) 
(32) 
(33) 
(34) 
(35) 
(36) 
(37) 
(38) 
(39) 
(40) 
(41) 
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substituting (40-41), (38-39), and (25) into (26) 
1 . 2 4K -1/2 2 
C(t) = {-[(K + l/T + v/T) - -] -[J., (K + l/T + v/T)][(K + l/T + v/T) 
T T 
J 2 4K 0 _ 4K
1
-1;2} _ [(K + l/T + v/T) +(K + l/T + v/T) - T]t + {- 1:.[(K 
T +1/2 e 
2 
T 
+ l/T + v/T)
2 
- 4K1-1 t 2 +[l, (K + l/T + v/T) l [ (K + l/T + v/T) 2 
T 
(K + l/T + V/T) - f(K + l/T + v/T) 2 - ~K 
- 4K]-l/2 + 3/2}· - [ ~· ]t 
T e 
factoring and simplifying 
(42) 
C(t) = { [.!.-i. (K + l/T + v/T) l [ (K + l/T + v/T) 2 - 4K1-1 t 2 + 1/2} 
T T e 
2 4K' 
(K + l/T + v/T) +/CK+ l/T + v/T) - --:;-
- ( 2 ] t + {[-1/T +'~ (K + l/T 
2 4K -1/2 
+ v/T)][(K + l/T + v/T) - -] + 1/2} 
T e 
j 2 4K' (K + l/T + V/T) - (K + l/T + V/T) 
- (~----------------T-]t 
2 
final form - normal 
C(t) = {[(v+l)/2T + l/T - K/2][(K + l/T + v/T) 2 - 4KJ-l/2 + 1/2} 
. T e 
l 2 4K' (K + l/T + V/T) + V(K + l/T + v/T) 
- (---------:2:----------~T-] t + {[ (v+l) /2T -
+ K/2][(K + l/T + v/T) 2 - 4KJ-l/Z + 1/2} 
T e 
J Z 4K' (K + l/T + v/T) - jK + l/T + v/T) - T 
- [ 2 l t 
II - with shunt: 
Q' 
let ~ = l/T' V = V /V K' VB , B L' 
(43) 
l/T 
(44) 
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final form - shunt Q.E.D. 
C(t) 
2 4K' J-1/2 } 
= {[(v+l)/2T' + l/T' - K'/2][K' + l/T' + v/T') - ~ + 1/2 e 
2 4K (K + l/T' + v/T') + + l/T' + v/T') - -, 
- ['---------"-
2
---------T-'-] t + { [ v/T + K'] • 
+ {[(v+l)/2T' - l/T' + K'/2][(K' + l/T' + v/T')
2 
- ~~·J-112 + l/2}e 
2 4K' (K' + l/T' + v/T') - (K' + l/T' + v/T') - "T""' 
- [---------L----------'-]t 
2 
Variable assignments: 
Normal: Independent 
QM - portal flow 
QH - hepatic arterial flow 
VB - blood volume, total 
VL - blood volume, liver 
KL - dye clearance constant 
Dependent 
QL=QH+QM 
TA = VB/QL 
V = VB/VL 
KU = KL*QL/VL 
Al = (KU -t: l/TA + V/TA) 
A2 = FSQT(Alt2-4*KU/TA) 
(45) 
Bl = (v+l) /2-kTA + l/TA - KU/2 
B2 = (v+l)/2*TA - l/TA + KU/2 
Shunt: Independent 
QM 
Program: 
QH 
VB same as normal 
VL 
KL 
R - blood fraction 
to liver' 
Dependent 
QK = QH + R*QM 
TB = VB/QK 
KV = KL*QK/VL 
A3 = (KV + l/TB + V/TB) 
A4 = FSQT(A3t2-4*KV/TB) 
B3 = (v+l)/2*TB + l/TB - KV/2 
B4 = (v+l)/2*TB - l/TB + KV/2 
1.1 F I=0, 240; S Z=FDIS(I,0); S Z=FDIS(0,I) 
1.2 F I=0, 10, 230; ~O 2 
2.1 F J=0,5; S Z=FDIS(I,J); S Z=FDIS(J,I) 
3.1 ASK QM,QH,VB,VL,KL,R 
3.2 S QL = QH+QM; S TA=VB/QL; S V=VB/VL; S KU=KL*QL/VL 
3.3 S Al = KU + l/TA+V/TA; S A2=FSQT(Alt2-4*KU/TA) 
3.4 S Bl= (v+l)/2*TA + l/TA - KU/2; S B2 = (v+l)/2*TA - l/TA + KU/2 
,3.5 S QK=QH+R*QM; S TB=VB/QK; S KV~KL*QK/VL 
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3.6 S A3=KV+l/TB+V/TB; S A4=FSQT(A3t2-4*KV/TB) 
3.7 S B3=(v+l)/Z*TB+l/TB-KV/Z; S B4=(v+l)/Z*TB-l/TB+KV/Z 
4.1 F T=l, 200; DO 5 
5.1 S CN=(Bl/AZ+0.5)*FEXP(((-Al-A2)/2)*T)+(BZ/AZ+o.S)*FEXP(((-Al+A2)/2)*T) 
S.Z S CS=(B3/A4+0.S)*FEXP(((-A3-A4)/2)*T)+(B4/A4+Q.S)*FEXP(((-A3+A4)/2)*T) 
5.3 S Z=FDIS(T,50+GN*SO); S Z=FDIS(T,SO+cS*50) 
Parameters: (Swenson, 1977) 
BW = ZZ.7 kg 
C.0 = 165 ml/kg/min = 3746 ml/min 
*VB = 9Z ml/kg = Z090 ml 
*VL = 0.07 vB = 146 ml 
QL = 40 ml/kg/min = 908 ml 
*QH = 1/3 QL = 303 ml 
*QM = 2/3 QL = 605 ml 
*KL < 0.5 mg/min 
*O < R < 1 (*computer variables) 
Half-time calculation: 
from (Z6) take 
log both sides 
grouping log 
terms on left 
side and f ac-
toring right 
side 
solving for t 
for normal case 
log 
log 
log 
c = -m1 t -m2t log(D1e ) +log (Dze 
c = -m1t log(D1) + log e + log Dz + log 
c - log D - log D = (-m - m )t 1 . 2 1 z 
log C - log D1 - log Dz T = i, (-m - m ) 
. 1 2 
for shunt case 
• 
• log c - log D1 - log Dz T = i, I I 
(-m - m ) 1 z 
(46) 
-m2t e . (47) 
(48) 
(49) 
(SO) 
(51) 
For c
112
, let C = 0.5. 
Program: 
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6.1 S Dl=Bl/A2+0.5; S D2=B2/A2+Q.5; S Ml=(-Al-A2)/2; S M2=(-Al+A2)/2 
6.2 S D3=B3/A4+0.5; S D4=B4/A4+D.5; S M3=(-A3-A4)/2; S M4=(-A3+A4)/2 
6.3 S Tl=(FLOG(0.5)-FLOG(Dl)-FLOG(D2))/(-Ml-M2) 
6.4 S T2=(FLOG(0.5)-FLOG(D3)-FLOG(D4))/(-M3-M4) 
6.5 S T3=(Tl/T2)*100 
6.6 T Tl,T2,T3! 
